The management concept of breast cancer with clinically node-negative/imaging node-positive disease

被引：4
|
作者：
Bi, Zhao [1 ,2 ]
Ren, Tong-Yue [1 ,2 ]
Zhang, Zhao-Peng [1 ,2 ]
Wang, Yong-Sheng [1 ,2 ,3 ,4 ]
机构：
[1] Shandong First Med Univ, Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
[2] Shandong Acad Med Sci, Jinan, Shandong, Peoples R China
[3] Shandong First Med Univ, Shandong Canc Hosp & Inst, Ji Yan Rd 440, Jinan 250000, Shandong, Peoples R China
[4] Shandong Acad Med Sci, Ji Yan Rd 440, Jinan 250000, Shandong, Peoples R China
来源：
INTERNATIONAL JOURNAL OF SURGERY | 2023年 / 109卷 / 11期
基金：
中国博士后科学基金;
关键词：
NEOADJUVANT CHEMOTHERAPY; ENDOCRINE THERAPY; SURGERY; RADIOTHERAPY; AXILLA; BIOPSY; TRIAL; WOMEN;
D O I：
10.1097/JS9.0000000000000664
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：3727 / 3729
页数：3
相关论文
共 50 条
  • [41] Management of clinically node-negative groin in patients with penile cancer
    Niyogi, Devayani
    Noronha, Jarin
    Pal, Mahendra
    Bakshi, Ganesh
    Prakash, Gagan
    [J]. INDIAN JOURNAL OF UROLOGY, 2020, 36 (01) : 8 - 15
  • [42] Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer
    Honselmann, Kim C.
    Pergolini, Ilaria
    Fernandez-del Castillo, Carlos
    Deshpande, Vikram
    Ting, David
    Taylor, Martin S.
    Bolm, Louisa
    Qadan, Motaz
    Wellner, Ulrich
    Sandini, Marta
    Bausch, Dirk
    Warshaw, Andrew L.
    Lillemoe, Keith D.
    Keck, Tobias
    Ferrone, Cristina R.
    [J]. ANNALS OF SURGERY, 2020, 272 (02) : 357 - 365
  • [43] Sentinel node biopsy in clinically node-negative tongue cancer
    Baek, Chung-Hwan
    [J]. ORAL ONCOLOGY, 2011, 47 : S23 - S24
  • [44] Management of the Clinically Node-Negative Axil la in Primary and Locally Recurrent Breast Cancer
    McGinity, Ashley C.
    Lautner, Meeghan A.
    Jatoi, Ismail
    [J]. SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 23 (03) : 463 - +
  • [45] Identification of gene expression differences in primary breast tumors from node-negative and node-positive women
    Field, L. A.
    Seebach, J. F.
    Love, B. J.
    Deyarmin, B.
    Kane, J.
    Hooke, J. A.
    Ellsworth, R. E.
    Shriver, C. D.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S243 - S243
  • [46] Lymph Node Yield at Radical Cystectomy Predicts Mortality in Node-negative and not Node-positive Patients
    Morgan, Todd M.
    Barocas, Daniel A.
    Penson, David F.
    Chang, Sam S.
    Ni, Shenghua
    Clark, Peter E.
    Smith, Joseph A., Jr.
    Cookson, Michael S.
    [J]. UROLOGY, 2012, 80 (03) : 632 - 638
  • [47] DIVERGENT EFFECT OF ADJUVANT CHEMO-IMMUNOTHERAPY ON RECURRENCE RATES IN NODE-NEGATIVE AND NODE-POSITIVE BREAST-CANCER PATIENTS
    SENN, HJ
    FOPP, M
    AMGWERD, R
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 393 - 393
  • [48] THE MORPHOMETRIC PROGNOSTIC INDEX IS THE STRONGEST PROGNOSTICATOR IN PREMENOPAUSAL LYMPH NODE-NEGATIVE AND LYMPH NODE-POSITIVE BREAST-CANCER PATIENTS
    VANDIEST, PJ
    BAAK, JPA
    [J]. HUMAN PATHOLOGY, 1991, 22 (04) : 326 - 330
  • [49] PROGNOSTIC VALUE OF LYMPH NODE CHARACTERISTICS IN PATIENTS WITH NODE-POSITIVE OR NODE-NEGATIVE EARLY-STAGE CERVICAL CANCER
    Chong, G. O.
    Lee, Y. H.
    Lee, H. J.
    Hong, D. G.
    Lee, Y. S.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A205 - A205
  • [50] TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer
    Overgaard, J
    Yilmaz, M
    Guldberg, P
    Hansen, LL
    Alsner, J
    [J]. ACTA ONCOLOGICA, 2000, 39 (03) : 327 - 333
12345